KRM-III is a potent and orally active T-cell antigen receptor (TCR) inhibitor. KRM-III inhibits TCR - and phorbol myristate acetate/ionomycin-induced activation of nuclear factor of activated T cells (NFAT) and T-cell proliferation with an IC 50 of ~5 μM. Anti-inflammatory activity.
规格
别名
核磁共振
规格或纯度
Moligand™, 10mM in DMSO
英文名称
KRM-III
生化机理
KRM-III 是一种强效的口服活性 T 细胞抗原受体(TCR)抑制剂。KRM-III 可抑制 TCR 和乙酸磷脂酰肉豆蔻酯/氧胺霉素诱导的活化 T 细胞核因子(NFAT)激活和 T 细胞增殖,IC 50 约为 5 μM。